chrisvoncsefalvay/vaers-outcomes huggingface dataset:
urinary tract infection; Got really sick; Chills; Fever/ high temperature; Feeling really tired; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection), VACCINATION COMPLICATION (Got really sick), VACCINATION SITE PAIN (Vaccination site pain), CHILLS (Chills) and PYREXIA (Fever/ high temperature) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 02-Mar-2021, the patient experienced VACCINATION COMPLICATION (Got really sick), CHILLS (Chills), PYREXIA (Fever/ high temperature) and FATIGUE (Feeling really tired). On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary tract infection). At the time of the report, URINARY TRACT INFECTION (urinary tract infection), VACCINATION COMPLICATION (Got really sick), VACCINATION SITE PAIN (Vaccination site pain), CHILLS (Chills), PYREXIA (Fever/ high temperature) and FATIGUE (Feeling really tired) outcome was unknown.            This case was linked to MOD-2021-032266 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: No specific follow-up information recorded.; Sender's Comments:  MOD-2021-032266:Crosslinked case
nausea, headache, muscle aches, fatigue, swollen lymphnodes in armpit (left side)
Pt was inadvertently given the pediatric dose for the 2nd dose. No adverse effects for the patient so far
Fatigue,  daily head ache, arm lumpy  with red rash, iitchy
I woke up with a slightly scratchy throat and was sneezing a lot and did not think much of it. I woke up with a scratchy throat again on Sunday May 8. I tested because we were going to go to church but the test was positive. I called my doctors office and they suggested that I not get the monoclonal antibodies. I was not really sick. We decided it was better to allow my body to build up the antibodies. I chose to quarantine on May 08, 2022. I did have a fever of 101.4 on Sunday night and by the next morning my fever was gone. I basically have a stuffy nose, sinus drainage and mild sinus headache. My only treatment has been vitamin C and Advil or Excedrin to treat a headache. The doctor advised me to retest with a PCR test.
Sore arm about 5 days, 1.5 temp 2 days, tired about 4 days
4 month old male patient was given a dose of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th September 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 8th September 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided are as follows: The case was reported by nurse on behalf of the patient's mother. The nurse reported that a 4 months old patient received a dose of Kinrix, which led to inappropriate age at vaccine administration. No symptoms were reported. The reporter stated that the patient's mother was not affiliated with the health care professional clinic that administered the vaccine. The reporter agreed to provide the patient's mother contact information in order to get the health care professional's contact information. The reporter did not have the patient's initials, date of birth, or lot/expiry date. The reporter consented to follow-up.
Patient received her first dose of Pfizer vaccine at 1500, she waited her required 15 minute observation time, was feeling fine and was released by the NP.  Patients mother drove her back at approximately 1530 reporting difficulty breathing, throat tightness, numbness and tingling or her face and tongue swelling.  RN assessed patient and administered 0.3mg of EPI and EMS was called per protocol. Patient reported some resolution after EPI was given. EMS transported patient to ER for further evaluation.
Currently pregnant. After vaccine I have experienced hand numbness, finger numbness and forearm numbness. Only in my Right hand/arm.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: Patient received the Pfizer COVID-19 vaccine on 7/8/21 at 10:17am. Patient called back around 4:00pm stating that she had developed a rash from the injection site that ran down her arm and across her chest several hours later. She stated that she felt completely fine and was surprised that this occured because it was not itchy. The patient was advised to speak with their PCP and to adminster benadryl. The patient was informed that this would be reported through the necessary channels.
REC'D TWINRIX AT 11:30 AM WHEN ITCH AND RASH AT 3:00 PM, CLIENT STATES TOOK BENADRYL FOR ALLERGIC REACTION. ALSO ON 2/24/2011 CLIENTS STATES AFTER REC'D TWINRIX AT 9:30 AM AND ATE AT 1:00PM, AROUND 3:00 PM STARTED WITH A RASH AND ITCH, DID NOT KNOW IF IT DUE TO IMM'S OR FOOD. ON THAT DAY CLIENTS SAW MD AND WAS GIVEN MEDS. INSTRUCTED CLIENT TO GO SEE MD IF ALLERGY GET WORSE.
Events:Freezing, severe headache, aches, labored breathing, stiffness, not able to sleep. Red/hot/raised bumps near injection site on right arm. Treatment: Tylenol, heating pad, water, hot shower, sleep, blankets, warm clothes.
Excrutiating shoulder (right) pain, radiating down to just below elbow, which is severely limiting movement at best; Symptoms have not ceased or decreased. 800 mg Ibuprofen & 1000 mg Tylenol taken up to 4x a day for pain.
Pt immunized with Fluvirin about 1015A; pt came back about 12N with c/o feeling faint and itching. Pt's eyes were glass-like and she was pale. HR 80bpm and regular. No SOB. No resp. difficulty noted but pt stated her throat felt funny. Pt medicated with Benadryl 50mg IM at 1210P, EMS called and pt transported to  ER at 1220pm.
Unspecified patients were inadvertently administered doses of Pedvaxhib, Gardasil 9 and Rotateq on unspecified dates that had been improperly stored; No addiitonal adverse event; This non-valid spontaneous report was received from a medical assistant referring to an unspecified number of patients of unknown demographics. There was no information provided about the patients' concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history.  On an unspecified date, unspecified patients inadvertently received improperly stored vaccines (Product storage error). The patients were vaccinated with doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot# 1637641, expiration date reported as 16-FEB-2022, lot# S008154, expiration date reported as 20-NOV-2021; with doses of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) Lot# S021458, expiration date reported as 27-FEB-2022, lot# S030965, expiration date reported as 03-APR-2022; and with doses of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot# S017630, expiration date 06-DEC-2020, lot# S004401, expiration date 15-NOV-2020 (exact doses, routes of administration, and anatomical sites for all vaccines were not reported). All vaccines were administered for prophylaxis.   The doses of the vaccines were stored at a temperature reported as -40 degrees Fahrenheit (F) for 4 hours and 50 minutes. There was no previous temperature excursion. Digital data logger was involved. No additional adverse effects were reported.  This case is non-valid due to lack of patient identifiers.
Information has been received from a physician concerning a 66 year old white female with a history of a (+) PPD tuberculosis test, a seizure disorder and hyperlipidemia who on 6/14/00 was vaccinated, IM, with a 1st dose of pneumococcal vaccine 23 polyvalent (lot 633103/1216J) in the right deltoid. Subsequently, the pt developed extensive edema and erythema in her right arm, malaise and myalgia. A dx of injection site cellulitis was determined. The pt was treated with rest, analgesics and oral cephalexin (Keflex). On 6/27/00, the pt recovered. It was also noted that another pt (WAES 00071379) experienced a similar reaction after vaccination with this same vaccine. No further information is available.
I had a scratchy throat and a bad headache. Everyone who had been to my brother's wedding was testing positive for COVID-19, so I took a home COVID-19 test, and it came back positive. I went to the local urgent care who confirmed my positive test result. They didn't prescribe any medication, they advised me to go home drink plenty of fluids and watch my oxygen.
Case number PHEH2015US003185 is an initial spontaneous report from a consumer (patient) received on 12 Feb 2015. This report refers to an adult female patient. Medical history was not reported. Concomitant medication included LOPRESSOR. Her vaccination history included administration of seasonal influenza vaccine (manufacturer and batch number: unknown). On an unknown date, after vaccination, she experienced mild flu that kept her away from lunar new year celebrations. After a week she felt better and went outside. Final outcome of the event was recovered. Seriousness and causality of the event was not reported.
Sore arm, chills, slight fever, headache, brain fog. Headache and brain fog lasted until Monday. Then 8 days later I woke up with very sore arm again and a big red circle around the injection site. My arm was also swollen. Same day, I also woke up with painful upper shoulder pain across both shoulders and upper back.  I have been more tired over these past 2 weeks and napping frequenlty.
Around 7 hours after injection, I noticed slight numbness in my ring and pinky fingers on my right hand. It is mild numbness, but since I noticed it, it has persisted for about 3 hours.
Symptoms began 1.6.21 evening from 1AM forward lasting through 1.8.21 5AM. Sympotms included: moderate-severe headache, nausea, chills/Moderate, whole body aches-moderate, site inject RT aches, imbalance/dizziness, symptoms highly mimicked how I felt when I had COVID-19 in Novemeber.
In the vein he feels like fireworks in the blood; vomiting; stomach hurts; tired; feels like there is something moving, float-afloat; This is a spontaneous report from a contactable consumer (patient wife). A 52-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 05Jun2021 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced in the vein he feels like fireworks in the blood, vomiting, stomach hurts, tired, feels like there is something moving, float-afloat. The reporter inquired if these are reported adverse events was reported for someone or not and states he received first dose fine.Patient received his second dose yesterday. He had some problem first but it was very mild after 14 hours. The outcome of events was unknown.   Follow up attempts are needed. Further information has been requested.
approx 1 hr p/shots, fever 106; throwing up; went to hosp;
This case was reported by a physician via other and described the occurrence of viral infection in a 18-year-old patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced viral infection (serious criteria hospitalization), injection site swelling (serious criteria hospitalization) and fever (serious criteria hospitalization). On an unknown date, the outcome of the viral infection, injection site swelling and fever were unknown. It was unknown if the reporter considered the viral infection, injection site swelling and fever to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The GSK medical affairs physician in the Vaccines group had given a BEXSERO promotional speaker program and during the program one of the physician attendees mentioned an adverse event in one of her patients who received BEXSERO. The physician after the program said that she had not reported the adverse event. She asked to call her office the next day to get more details, however on call he was told the physician would call him back. The physician had not called back. The reporter did not know the exact dates of vaccination. The patient developed injection site swelling and very high fever, therefore went to the Emergency Room of a hospital. The patient was hospitalized overnight for observation. Discharge diagnosis was viral infection. At the time of reporting, the patient had not returned for 2nd dose of BEXSERO.
This spontaneous report as received from a healthcare worker refers to a 16 year old patient (gender unknown). On 13-MAY-2013 the patient was vaccinated with two doses of GARDASIL (lot # H020002) (dose not reported, intramuscular route in the left arm). Concomitant therapy was not reported. The patient had not demonstrated or reported any adverse effects. Additional information has been requested.
REDNESS AND SWELLING AT INJECTION SITE APPROXIMATELY 1 1/2 INCHES IN DIAMETER.  SWELLING IS A HARD, SORE LUMP.  ADVISED PATIENT TO WARM PACK SEVERAL TIMES A DAY.  IF NO IMPROVEMENT OR WORSENING OF SITE CONTACT CLINIC/PROVIDER
pt recvd vax; devel edema, erythema & pruritus at inject site;
Woke up at 4 am with a headache and being really warm. Took them and it was 101.5 then I took Tylenol and temp came back to normal around 9 am. Was sluggish weak tired for a few days a little nauseous with no appetite for two days.
pt states that about an hour after getting the vax her throat started closing up as well as developing a rash along with some whelps on her face, ear and arm.  Her heart rate was up and fluttering.   Later she was nauseated, had vomiting, diarrhea, dizziness, cough, SOB, swollen lymph nodes, sweating, chills and pounding headache.  Pt contacted PCP and was instructed to go to the ER.  She made 4 attempts to go ER but never able to get there due to having dizzy spells and diarrhea incidents.  She called her PCP back to let them know she never made it to the ER.  She was prescribed albuterol inhaler,  famotidine, ondansetron, dexamethasone, and drink Pedialyte. Pt had a FU phone visit w/ PCP and was instructed to take Imodium. On 3/19/2021 she said her heart was feeling better and her symptoms were starting to get better.  She went to PCP on 3/20/2021 where they did blood work w/ pending results and has a FU appt on 3/26/2021.  Pt still has symptoms but is some better.
17 years old received Havrix adult dose; 17 years old received Havrix adult dose; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 17-year-old female patient who received HAV (Havrix adult) (batch number K4Y4L, expiry date 17th June 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th August 2021, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 10th August 2021, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that a 17 year old patient received Havrix adult, which led to overdose and adult product administered to child. The reporter did not consented to follow up.
Site of injection much more sore than any previous vaccine (was sore for 7 days, past vaccines sore for half a day). Back pain much worse than expected for given amount of physical activity (eccess back pain lasted for one day). Forehead broke out in red bumps, smaller red bumps on cheeks and chest.
Thirty minutes after vaccination, I began having a headache that was a different type of headache than my usual headaches. It was right sided headache that was elevated in intensity for 2-3 days. I had extreme fatigue and my right arm hurt to move, all the way down to wrist (lasted 3 to 4 days). The same night of the vaccine, I woke up with moderate shortness of breath and right sided neck edema. I noticed right sided neck/jaw pain, right sided sternum pain between the scapula and spine that lasted 3-4 days. The next day after vaccination, I had increased vertigo and diarrhea/stomach cramping which lasted 3-4 days. Four days after vaccination, I began having upper back pain. Most all of the symptoms lasted between 4 days to one week except the fatigue which lasted 5 weeks. I spoke with my pcp about the symptoms on 4-22-2021 during a routine visit. I don't know if I have fully recovered because I am still having fatigue/vertigo continues to the point that I have to now use a wheelchair in my home where I only had to use it on outings before. The vaccine may have intensified previous symptoms.
On May 19th, nineteen days after my second Pfizer vaccine, I collapsed at the farmer's market. I was vomiting, sweating intensely, with my heart racing at 180 bpm.  A stranger called 911 and I was given adenosine in the ambulance to stop my heart to break the cycle and reset my heart rhythm. I could have died. After multiple tests in the hospital,  I was told that I had SVT supra ventricular tachycardia.  A second cardiac episode occurred on June 1st, and I was once again given adenosine in the ambulance to stop my racing heart at 190 BPM and taken to the hospital where I stayed for 2 days.  After speaking with several cardiologists, I was told that I had to have a heart procedure.  On June 21,  I had a heart ablation, and I am still recovering.
This spontaneous report was received from a female consumer reporting on herself who on an unknown date was vaccinated with a dose of pneumococcal vaccine (manufacturer unknown) (dose, route and lot # not provided). On an unknown date, the patient became very sick 48 hours after receiving the pneumonia vaccine. The consumer stated that she had both coughing and congestion. No Product Quality Complaint was reported. On an unknown date, the patient recovered from the events. The patient sought unspecified medical attention. Additional information has been requested.
Extreme itchiness within minutes of injection, swelling from top of shoulder down to elbow, hot to touch, redness, hard knot, extreme soreness upon moving.
Information has been received from a nurse practitioner concerning a 70 year old female with iodine allergy, hyperlipidaemia and asthma who on 21-MAY-2008 was seen for an office visit related an exacerbation of asthma.  On the same day, the patient was vaccinated subcutaneously in the right arm with a first dose of ZOSTAVAX (LOT# 659409/0409X).  Concomitant therapy included simvastatin (manufacturer unknown), SPIRIVA, ADVAIR and PROAIR HFA.  On 22-MAY-2008 the patient developed swollen lips and rash subsequent to vaccination with ZOSTAVAX and then went to Emergency room on 23-MAY-2008.  The patient was prescribed Prednisone, Benadryl, Xyzal and Zantac.  On 28-MAY-2008, the patient was seen in the office after her symptoms previously reported.  The note indicated a "possible reaction to ZOSTAVAX."  The patient's concurrent condition of asthma was improved.  The patient was taking ADVAIR.  Subsequently, the patient recovered from swollen lips and rash.  On 04-JUN-2008, the nurse practitioner saw the patient because the patient felt that her tongue was swollen.  At the time of the report, the patient had recovered.  The reporter considered the patient's event to be serious as other important medical events and felt that swollen lips and rash were related to therapy with ZOSTAVAX.  Additional information has been requested.
Initial report was received on 12 June 2013 from a health care professional. An 11 year-old female patient who had not acute or chronic illness at the time of vaccination and who had seasonal allergies had received on 06 March 2013 an intramuscular left deltoid dose of MENACTRA, lot number U4418AA and an intramuscular left deltoid dose of ADACEL, lot number C4366AA and on 17 April 2013 developed headaches, weakness of both legs and arms from elbows to fingers, fever 101-103, difficulty walking and back pain. The patient was diagnosed with GBS and was hospitalized for five days on 28 May 2013. Diagnostic tests and laboratory data included a lumbar puncture, CT scan of head and abdomen, lumbar films, sinus x-rays, CBC (complete blood count), UA/C&S (urine for culture and sensitivity), AST and glucose (results were not reported). Concomitant therapy included allergy shots. The patient was receiving at home PT (physical therapy). No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: none.
Mild fever, night sweats, tiredness, raised itchy red welts all over the body.  Effects lasted 2 days.   No treatment used other than time off from work and lots of sleep.
Auditory hallucinations, muscle seizures (clenched fists repetitive stretching), fever, restlessness, whimpering pain for 8 hours.
This is a prospective pregnancy case. This 23-year-old female subject was enrolled in an open label study titled BOOSTRIX Pregnancy Registry: a prospective, exploratory, cohort study to detect and describe any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with BOOSTRIX during pregnancy or within 28 days preceding conception. The subject received BOOSTRIX (injection) .5ml on 29th December 2014. The subject's last menstrual period was on 19th May 2014 and estimated date of delivery was 23rd February 2015. The subject received BOOSTRIX at week 32 of the pregnancy and during the third trimester of pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. Additional information received on 29 December 2014: The type of conception was normal (no in-vitro fertilization).
The event was a vaccine administration error rather than being a true adverse event at this time. Our pharmacy mistakenly scheduled patient for his second Moderna shot THREE weeks after he received his first dose (5/25/21), and I administered the shot. Realizing the error later in the day, I called patient to alert him to our error. He said he was feeling fine at that time. I gave him the VAERS phone number to use in the event he experiences any adverse effects, and I asked him to report any potential issues to our pharmacy as well.
For both doses of vaccine. Day 3: fatigue, muscle weakness, blurry vision. Day 5: fever, nerve twitching in left arm, numbness, difficulty breathing. Day 6: Nerve twitching, some prickling, though not as severe as before. First dose also lead to migraine with aura but at the end of the second week; there were outside stressors also so not sure if it'll happen again.